Document Detail

Mexiletine and persistent ophthalmic changes.
MedLine Citation:
PMID:  15102256     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Mexilitine is an anti-arrhythmic agent used to treat neuropathic pain. The drug has a low side-effect profile with gastritis as the predominant complaint. The following two cases suggest that mexilitine can potentially cause persistent ophthalmic changes and should be used with caution in chronic pain patients with preexisting ocular disease.
M S Leong; F Isolani; R R Gaeta
Related Documents :
2062756 - Sepsis and septic shock. deadly complications that are on the rise.
12016606 - Use of compounded topical analgesics--results of an internet survey.
17309706 - Pharmacotherapy for neuropathic pain.
3897936 - Pharmacologic therapy of aphakic and pseudophakic cystoid macular edema. 1985 update.
10724826 - Intraocular lens calculations status after corneal refractive surgery.
7661266 - A comparison of intraarticular morphine and bupivacaine for pain control after outpatie...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Pain medicine (Malden, Mass.)     Volume:  2     ISSN:  1526-2375     ISO Abbreviation:  Pain Med     Publication Date:  2001 Sep 
Date Detail:
Created Date:  2004-04-22     Completed Date:  2005-04-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100894201     Medline TA:  Pain Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  228-9     Citation Subset:  -    
Division of Pain Management, Department of Anesthesiology, Pain Management Services, Stanford University School of Medicine, Stanford, California, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Transdermal fentanyl: little absorption in two patients with systemic sclerosis?
Next Document:  Treatment of genitofemoral neuralgia after laparoscopic inguinal herniorrhaphy with fluoroscopically...